Skip to Main Content

Paper Details

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants.
Nat Commun
8
2023
ACE2, Beta variant, Beta/B.1, CoV2373, Mice, Omicron, SARS, SARS-, SARS-CoV, SARS-CoV-2, WA1/2020, baboons, mice, murine, rS, rS-, rS-Beta, rS-WU1
Author NameAffiliation
James LogueThe University of Maryland School of Medicine
James LogueCenter for Pathogen Research, The University of Maryland School of Medicine
Stuart WestonThe University of Maryland School of Medicine
Stuart WestonCenter for Pathogen Research, The University of Maryland School of Medicine
Holly HammondThe University of Maryland School of Medicine
Holly HammondCenter for Pathogen Research, The University of Maryland School of Medicine
Holly HammondJohns Hopkins University
Matthew B FriemanThe University of Maryland School of Medicine
Matthew B FriemanCenter for Pathogen Research, The University of Maryland School of Medicine
Matthew B FriemanThe University of Maryland School of Medicine
Matthew B FriemanCenter for Pathogen Research, The University of Maryland School of Medicine
  • 1 - 11

Datasets

Release 1.2